Newswire BIZ
  • Latest News
    Services
    Legal
    Law
    Health
    Family
    Business
    Education
    Automotive
    Banking
    Advertising
    Construction
    Internet
    Real Estate
    Medical
    Beauty
    Marketing
    Technology
    Food
    Latest News →
  • Submit Release
  • My Account
  • Login
  • Create Free Account

Fisetin - CAS 528-48-3


Posted November 24, 2019 by BOC_Science

Fisetin (Fustel) is a potent sirtuin activating compound (STAC) and an agent that modulates sirtuins.
 
Feature News
COMMA Shares a Service Design Approach to Enterprise AI Adoption
SunKnowledge Expands Specialty Revenue Cycle Support as Payer Demands and Administrative Burdens Climb
Spectrum Unlocked Launches: Free Tools, State Benefit Guides, and Resources for Autism Parents
Edison Institute of Nutrition Marks 30th Anniversary as a Canadian Online Nutrition School
Immigration Lawyers Serving Philadelphia
Law Offices of Dizengoff and Yost In Hammonton, New Jersey
Dentist In Philadelphia Dr. Yurovsky
Place Your News Here
Fisetin (Fustel) is a potent sirtuin activating compound (STAC) and an agent that modulates sirtuins.More at:https://www.bocsci.com/fisetin-cas-528-48-3-item-70598.html
 
Share Facebook Twitter Linkedin
DisclaimerReport Abuse Content Requests Print Friendly and PDF
Contact Email [email protected]
Issued By BOC Sciences
Country United States
Categories Biotech
Last Updated November 24, 2019
Asimadoline - CAS 153205-46-0
Halofuginone - CAS 55837-20-2
Epirubicin Hydrochloride - CAS 56390-09-1
Demecarium bromide - CAS 56-94-0
Ibuprofen Lysine - CAS 57469-77-9
Magnolol - CAS 528-43-8
Enjoy your ultimate Manaus Jungle Tours
Choose the ultimate Brother sewing machines for your requirement
TokeQQ Stands the Best Situs Dominoqq Online Offering Interesting Advantages to Members
Ahealthgui Provides Fair Flat Belly Fix Review to Help Fitness Freaks

About ARC

Privacy Policy

Terms of Service

Brand Assets

Contact Us

News By Category

News By Date

News By Country

News Sitemap

Media Network

PRFree

PRBase

©2013-2026 NEWSWIREBIZ.COM